← brief for 2026-09-28 · Slowing decline

Targeting the aldosterone–mineralocorticoid receptor pathway in cardiovascular–kidney–metabolic syndrome

Key takeaways

This is a review article, not a new trial. It discusses evidence that blocking the aldosterone pathway can help people with combined heart, kidney, and metabolic disease. It summarizes existing studies but does not report new results from a single trial.

Source

Paper · Nature Reviews Nephrology · 2026-09-28
https://www.nature.com/articles/s41581-026-01125-6